Advertisement

Health

Schering-Plough Profit up 55%

Share:

by publicreader | April 19, 2007 at 08:03 am

853 views | 0 Recommendations | 0 comments

Schering - Plough's leading drugs for cholestrol fighters rose 21% over a year to fuel record setting earnings for the company. The best sellers are co-marketed with Merck.

posted a 55 percent rise in first-quarter earnings, beating analysts' estimates on sharply higher sales of its prescription drugs, including two cholesterol fighters sold in partnership with Merck & Co. (MRK.N: Quote, Profile , Research)

Profit increased to $543 million, or 36 cents per share, from $350 million, or 24 cents per share, a year earlier.

Advertisement

Advertisement

0

0 See all footage | View Slideshow

Share: email story | add to any | | facebook | stumbleupon

in New York, Business, New Jersey, Health, sales, beating, prescription, forecasts, Jumps, drug, Pharmaceuticals, partnership, CENTS, Profit, Quote, profile, FIGHTERS, Higher, Percent, Merck, cholesterol, analysts, increased, included, sold, sharply, earned, estimates, Schering-Plough, first-quarter

I want to write something I've got photos and video

Tell me how to get published

Author

publicreader

Seattle, Washington, United States

See publicreader's recent stories

Advertisement

email story to a friend

is reporting from

Send Message
Add to favourites
Get RSS feed

Member
NP Rank: